Author:
Grome Heather N.,Grass Julian E.,Duffy Nadezhda,Bulens Sandra N.,Ansari Uzma,Campbell Davina,Lutgring Joseph D.,Gargis Amy S.,Masters Thao,Kent Alyssa G.,McKay Susannah L.,Smith Gillian,Wilson Lucy E.,Vaeth Elisabeth,Evenson Bailey,Dumyati Ghinwa,Tsay Rebecca,Phipps Erin,Flores Kristina,Wilson Christopher D.,Czaja Christopher A.,Johnston Helen,Janelle Sarah J.,Lynfield Ruth,O’Malley Sean,Vagnone Paula Snippes,Maloney Meghan,Nadle Joelle,Guh Alice Y.
Publisher
Centers for Disease Control and Prevention (CDC)
Reference43 articles.
1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019 [cited 2024 Apr 22]. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
2. Centers for Disease Control and Prevention. COVID-19: US impact on antimicrobial resistance [cited 2024 Apr 22]. https://www.cdc.gov/drugresistance/pdf/covid19-impact-report-508.pdf
3. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace.;Logan;J Infect Dis,2017
4. Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010.;Braykov;Infect Control Hosp Epidemiol,2013
5. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012–2013.;Guh;JAMA,2015